Ausgangslage
London-based pharmaceutical company EUSA Pharma markets new drugs to combat serious diseases.
We were informed by the equity firm Essex Woodlands, which had invested in EUSA Pharma, and by the latter company itself that it was on the look-out for innovative drugs as part of its growth strategy.
